Literature DB >> 1960216

Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic.

L Agatensi1, F Franchi, F Mondello, R L Bevilacqua, T Ceddia, F De Bernardis, A Cassone.   

Abstract

Non-pregnant, non-diabetic outpatients were examined for the presence of pathogenic vaginal yeasts to determine if a correlation existed between a specific yeast and clinical disease. Yeasts were isolated as single vaginal species from 186 of 228 subjects with clinically diagnosed candidal vaginitis, as well as from 122 out of 380 asymptomatic, age-matched controls. Apart from Candida albicans and C glabrata, other prevalent species were C krusei, C parapsilosis and Saccharomyces cerevisiae which accounted for 9.2%, 6.0% and 5.4%, and 9.0%, 2.4% and 19.7%, of yeasts from patients and carriers, respectively. Only C albicans and C parapsilosis were significantly more common in those with vaginitis. Only the isolates of these two species secreted aspartyl proteinase in vitro, and the amount of the enzymes secreted by the isolates from patients was significantly higher than that secreted by the isolates from carriers. These two species consistently produced vaginal infection in pseudoestrus rats, whereas none of the non-proteolytic species tested (C glabrata, C krusei, and S cerevisiae) colonised the vagina in these rats. Proteinase secretion correlated with experimental vaginal infection; it could also be a reliable factor for distinguishing clinically active infection from asymptomatic fungal carriage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960216      PMCID: PMC496666          DOI: 10.1136/jcp.44.10.826

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  How useful are symptoms in the diagnosis of Candida vaginitis?

Authors:  J J Bergman; A O Berg
Journal:  J Fam Pract       Date:  1983-03       Impact factor: 0.493

Review 2.  Candida infections: an overview.

Authors:  F C Odds
Journal:  Crit Rev Microbiol       Date:  1987       Impact factor: 7.624

3.  Experimental rat vaginal infection with Candida parapsilosis.

Authors:  F De Bernardis; R Lorenzini; L Morelli; A Cassone
Journal:  FEMS Microbiol Lett       Date:  1989-11       Impact factor: 2.742

Review 4.  Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

5.  Critical role of germ tube formation in the pathogenesis of candidal vaginitis.

Authors:  J D Sobel; G Muller; H R Buckley
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

6.  Hormonal factors in vaginal candidiasis in rats.

Authors:  O S Kinsman; A E Collard
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

7.  Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology.

Authors:  A O Berg; F E Heidrich; S D Fihn; J J Bergman; R W Wood; W E Stamm; K K Holmes
Journal:  JAMA       Date:  1984-02-03       Impact factor: 56.272

8.  Importance of differential diagnosis in acute vaginitis.

Authors:  R L Sweet
Journal:  Am J Obstet Gynecol       Date:  1985-08-01       Impact factor: 8.661

9.  Isolation, acid proteinase secretion, and experimental pathogenicity of Candida parapsilosis from outpatients with vaginitis.

Authors:  F De Bernardis; R Lorenzini; R Verticchio; L Agatensi; A Cassone
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

10.  Keratinolytic proteinase produced by Candida albicans.

Authors:  M Hattori; K Yoshiura; M Negi; H Ogawa
Journal:  Sabouraudia       Date:  1984
View more
  17 in total

1.  In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Authors:  J R Naglik; G Newport; T C White; L L Fernandes-Naglik; J S Greenspan; D Greenspan; S P Sweet; S J Challacombe; N Agabian
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights.

Authors:  Melissa A Kennedy; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

3.  High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women.

Authors:  F de Bernardis; F Mondello; G Scaravelli; A Pachì; A Girolamo; L Agatensi; A Cassone
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.

Authors:  M G Agresti; F de Bernardis; F Mondello; R Bellocco; G P Carosi; R M Caputo; F Milazzo; F Chiodo; V Giannini; L Minoli
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

5.  Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates.

Authors:  B Posteraro; M Sanguinetti; G D'Amore; L Masucci; G Morace; G Fadda
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

Review 6.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

Review 7.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects.

Authors:  F De Bernardis; M Boccanera; L Rainaldi; C E Guerra; I Quinti; A Cassone
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 9.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

10.  Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection.

Authors:  F De Bernardis; D Adriani; R Lorenzini; E Pontieri; G Carruba; A Cassone
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.